Product Information
PROPAFENONE HCL 150 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.1148 per EA under NDC 62559023001. Its NADAC has been published 594 times since May 20, 2015.
FDA first approved this application on Apr 23, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559023001
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PROPAFENONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076550FDA Approved
4/23/2004
TE Code
AB
On Market Since
3/31/2015
Pharmacological Classes
Price Statistics
The NADAC for PROPAFENONE HCL 150 MG TABLET has been published 594 times since May 20, 2015, and over the history we have for it it has declined 30.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1148 per EA |
|---|---|
| All-time high | $0.1951 (Jul 15, 2015) |
| All-time low | $0.1035 (Nov 20, 2024) |
| 52-week high | $0.1170 |
| 52-week low | $0.1081 |
| Median price | $0.1473 |
| Average price | $0.1442 |
| Largest weekly change | +31.1% (Nov 22, 2023) |
| Weeks tracked | 594 |
| Tracking since | May 20, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Propafenone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiarrhythmic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROPAFENONE HCL 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PROPAFENONE HCL 150 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.1148 per EA (NDC 62559023001), effective Sep 30, 2026.
How has the price of PROPAFENONE HCL 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for PROPAFENONE HCL 150 MG TABLET has declined 30.9%. It has been tracked across 594 weekly CMS publications since May 20, 2015.
What are the highest and lowest recorded NADAC prices for PROPAFENONE HCL 150 MG TABLET?
Since May 20, 2015, the NADAC for PROPAFENONE HCL 150 MG TABLET has ranged from a low of $0.1035 (Nov 20, 2024) to a high of $0.1951 (Jul 15, 2015), with a median of $0.1473 per EA.
Are there cheaper alternatives to PROPAFENONE HCL 150 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PROPAFENONE HCL 150 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PROPAFENONE HCL 150 MG TABLET?
PROPAFENONE HCL 150 MG TABLET (NDC 62559023001) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.